Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam or dexmedetomidine for prevention of perioperative respiratory adverse events in pediatric tonsillectomy
ChiCTR2000038359Phase 4Recruiting
- Sponsor
- Xuzhou Medical University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in respiratory complication comparing Placebo group, Midazolam group and Dexmedetomidine group (3 arms). Primary endpoint: Perioperative Respiratory Adverse Events. Started Oct 2020; status: recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
respiratory complication
Beyond the preview
Go deeper on ChiCTR2000038359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038359.